TARIQ ABO-KAMIL

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology HENDERSON, NC NPI 1124077664

General Payments — all program years on this page

$1,638.61

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 94
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $213.27 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $213.2712

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $235.6515
2019 $337.5617
2020 $183.6212
2021 $192.2711
2022 $231.4513
2023 $244.7914
2024 $213.2712

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086129224 Bayer Healthcare Pharmaceuticals Inc. $20.41 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086251714 Bayer Healthcare Pharmaceuticals Inc. $27.48 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104214009 AstraZeneca Pharmaceuticals LP $18.35 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105856272 AstraZeneca Pharmaceuticals LP $14.03 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116711967 GlaxoSmithKline, LLC. $13.93 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117881020 Boehringer Ingelheim Pharmaceuticals, Inc. $13.90 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118847388 Otsuka America Pharmaceutical, Inc. $24.15 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135455315 Lilly USA, LLC $18.74 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135473612 Lilly USA, LLC $19.19 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139765084 GENZYME CORPORATION $14.71 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149925905 Travere Therapeutics, Inc. $6.81 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150674255 Aurinia Pharma U.S., Inc. $21.57 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.